Alkermes (ALKS) Stock Price Target 2026

The average analyst price target for Alkermes is $53.05, 14.9% above the current price. Of 18 analysts, 14 rate it Buy, 3 Hold and 1 Sell. Targets range from $32 to $68. The latest change came on Nov 4, 2026, when RBC Capital raised its price target on Alkermes from $56 to $57 and kept an Outperform rating.

The Average Analyst Price Target for Alkermes is $53.05.

Price Target Range — 13 Quarters

Analyst Consensus — 18 Analysts

14Buy

3Hold

1Sell

Consensus RatingBuy# Analysts18Avg. Consensus PT$53.05Upside to Avg. PT+14.9%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Alkermes Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 4, 2026	RBC Capital	Leonid Timashev	PT Raise	Outperform	$56→$57
Nov 4, 2026	Wells Fargo	Benjamin Burnett	PT Raise	Overweight	$65→$68
Nov 4, 2026	HC Wainwright & Co.	Douglas Tsao	PT Raise	Neutral	$43→$50
Sep 24, 2026	Goldman Sachs	Andrea Newkirk	Reinstates	Neutral	$50
Sep 22, 2026	RBC Capital	Leonid Timashev	Maintained	Outperform	$56
Sep 22, 2026	Baird	Joel Beatty	PT Raise	Outperform	$58→$61
Sep 21, 2026	Needham	Ami Fadia	Maintained	Buy	$62
Jul 29, 2026	JP Morgan	Jessica Fye	PT Raise	Neutral	$60→$61
Jul 29, 2026	Baird	Joel Beatty	PT Raise	Outperform	$48→$58
Jul 28, 2026	Piper Sandler	David Amsellem	PT Raise	Overweight	$43→$65
Jul 20, 2026	Stifel	Paul Matteis	PT Raise	Buy	$45→$63
Jul 13, 2026	Needham	Ami Fadia	PT Raise	Buy	$61→$62
Jul 13, 2026	JP Morgan	Jessica Fye	Reinstates	Neutral	$60
Jul 2, 2026	Mizuho	Uy Ear	PT Raise	Outperform	$53→$65
Jun 29, 2026	Wells Fargo	Benjamin Burnett	PT Raise	Overweight	$44→$65
Jun 29, 2026	B of A Securities	Jason Gerberry	Downgrade	Neutral→Underperform	$38
Jun 24, 2026	Needham	Ami Fadia	PT Raise	Buy	$54→$61
Jun 22, 2026	TD Cowen	Joseph Thome	PT Raise	Buy	$42→$50
Jun 18, 2026	Needham	Ami Fadia	PT Raise	Buy	$50→$54
Jun 9, 2026	RBC Capital	Leonid Timashev	PT Raise	Outperform	$45→$56